DGKA and cancer: Recently, increasing attention has been paid to DGKα as a potential target for anti-cancer treatments including cancer immunotherapy (Dominguez et al., 2013; Purow, 2015; Sakane, Mizuno & Komenoi, 2016; Liu et al., 2016; Noessner, 2017).